NEW YORK (GenomeWeb News) — Clinical Data today said it has installed a 454 Life Sciences GS FLX genome sequencer in one of its Cogenics labs in Europe, and has signed a co-marketing agreement with Roche Diagnostics to support its sequencing plans.
Cogenics said Roche, which sold it the sequencer, will help it market sequencing and genome-wide expression profiling services to clients worldwide.
Robert Bondaryk, Cogenics’ senior vice president and general manager, said the company expects the agreement to contribute increased sales and revenues by consolidating its position as a genomics and pharmacogenomics services provider.
Financial terms of the agreement were not released.